Our data support the hypothesis of a “tuning CIN to optimize tumor fitness” [29] by elucidating a novel molecular mechanism that highlight the role of the RNA binding protein HNRNPL as the tiebreaker for the miR-155 targeting of BUB1. Here, HNRNPL is linked to neoplasm.